Ridgemont Equity Partners Buys Gallus Biopharmaceuticals

Middle-market buyout shop Ridgemont Equity Partners has acquired a majority stake in Gallus Biopharmaceuticals, a biologics contract manufacturing company based in St. Louis, Mo. Terms of the deal were not disclosed. Ridgemont Equity Partners is a Charlotte, N.C.-based private equity firm.

DealsNorth AmericaUSBriefs